The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.

NEW ORLEANS — For contrast-enhanced imaging in multiple sclerosis (MS), all gadolinium-based agents accumulate in body tissue but to greatly varying degrees. While the long-term effect of gadolinium ...

Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

The approval is based on global Phase III QUANTI studies evaluating Ambelvist's efficacy and safety in adults and children.

There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive decline, according to a new study presented today at the annual meeting of the Radiological Society of ...

Reveal's New Manganese-Based MRI Contrast Agent Advances Safer Patient Care · globenewswire.com CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Contrast agents used in MRI scans to improve the ...

New research suggests gadolinium retention may be more widespread and may be present in many more, or possibly all, patients exposed to gadolinium-based contrast agents, according to new research.

Gadolinium-enhanced MRI is associated with an increased risk of stillbirth or neonatal death, as well as rheumatologic, inflammatory, or infiltrative skin conditions. MRI use in the first trimester of ...

Actor and martial artist Chuck Norris claims that his wife was poisoned by a chemical used in MRIs — an issue the medical community says needs further research. The Norrises have sued 11 medical ...

The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...